Bidirectional communication between spinal cord injury and gut microbiota, from the bench to the bedside
-
By
-
Zhaoyang Yin
-
Ge Gong
-
Jian Yin
-
June 19, 2026
-
Clinical Scorecard: Interplay Between Gut Microbiota and Spinal Cord Injury: Insights from Laboratory Research to Clinical Application
At a Glance
| Category | Detail |
|---|
| Condition | Spinal Cord Injury (SCI) |
| Key Mechanisms | Gut microbiota dysbiosis and its impact on neuroinflammation and intestinal function. |
| Target Population | Individuals with spinal cord injury. |
| Care Setting | Clinical and laboratory research environments. |
Key Highlights
- Spinal cord injury disrupts intestinal function and alters gut microbiota.
- Gut microbiota can serve as biomarkers for SCI severity.
- Microbiota-derived metabolites may influence secondary inflammatory responses post-injury.
- Current treatments for SCI remain ineffective and standardized approaches are lacking.
- The gut microbiota-gut-spinal cord axis theory is gaining attention in SCI research.
Guideline-Based Recommendations
Diagnosis
- Assess gut microbiota composition in patients with SCI.
Management
- Consider microbiota modulation strategies such as probiotics and dietary interventions.
Monitoring & Follow-up
- Monitor changes in gut microbiota and inflammatory markers post-SCI.
Risks
- High-dose antibiotics may disrupt gut microbiota balance in SCI patients.
Patient & Prescribing Data
Patients with spinal cord injury experiencing gut dysbiosis.
Potential therapeutic targets include microbiota-derived metabolites and probiotics.
Clinical Best Practices
- Implement early interventions to address gut dysfunction post-SCI.
- Utilize a multidisciplinary approach to manage complications arising from SCI.
Related Resources & Content
